Detalhe da pesquisa
1.
Development and initial psychometric evaluation of the hepatitis C virus-patient-reported outcomes (HCV-PRO) instrument.
Qual Life Res
; 23(2): 561-70, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24005885
2.
Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial.
Qual Life Res
; 23(3): 877-86, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24036634
3.
Economics of switching to second-line antiretroviral therapy with lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda and Kenya.
Value Health
; 14(8): 1048-54, 2011 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-22152173
4.
Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data.
Cost Eff Resour Alloc
; 9: 5, 2011 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-21548986
5.
Psychometric development and validation of the chronic constipation treatment satisfaction questionnaire (CTSAT-Q).
Value Health
; 12(6): 1004-10, 2009 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-19490553
6.
Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women.
Health Qual Life Outcomes
; 4: 42, 2006 Jul 11.
Artigo
Inglês
| MEDLINE | ID: mdl-16834773
7.
Patient health utility, work productivity, and lifestyle impairment in chronic hepatitis C patients in France.
Clin Res Hepatol Gastroenterol
; 39(3): 307-14, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25511922
8.
Costs and absence of HCV-infected employees by disease stage.
J Med Econ
; 18(9): 691-703, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26047262
9.
Cost-minimization comparison of darunavir plus ritonavir and lopinavir/ritonavir in HIV-1 infected treatment-naïve women of childbearing age.
J Med Econ
; 17(4): 250-8, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24351091
10.
Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: a cost-effectiveness analysis for the United States.
Pharmacoeconomics
; 31(5): 427-44, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23620210
11.
All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome.
Postgrad Med
; 123(3): 122-32, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21566422
12.
Insomnia medication use and the probability of an accidental event in an older adult population.
Drug Healthc Patient Saf
; 2: 225-32, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-21701634
13.
Association of insomnia with quality of life, work productivity, and activity impairment.
Qual Life Res
; 18(4): 415-22, 2009 May.
Artigo
Inglês
| MEDLINE | ID: mdl-19288223
14.
Health benefit costs and absenteeism due to insomnia from the employer's perspective: a retrospective, case-control, database study.
J Clin Psychiatry
; 70(8): 1098-104, 2009 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-19758521
15.
A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.
Curr Med Res Opin
; 25(6): 1343-53, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19419339
16.
Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US.
Curr Med Res Opin
; 24(11): 3085-96, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18826750